Omega Common Stock Total Equity from 2010 to 2024

OHI Stock  USD 39.81  0.80  1.97%   
Omega Healthcare's Common Stock Total Equity is increasing with slightly volatile movements from year to year. Common Stock Total Equity is predicted to flatten to about 14.5 M. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
2002-12-31
Previous Quarter
23.4 M
Current Value
24.1 M
Quarterly Volatility
239.5 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Omega Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omega Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 335.7 M, Interest Expense of 247.3 M or Selling General Administrative of 85.6 M, as well as many indicators such as Price To Sales Ratio of 5.5, Dividend Yield of 0.1 or PTB Ratio of 1.26. Omega financial statements analysis is a perfect complement when working with Omega Healthcare Valuation or Volatility modules.
  
Check out the analysis of Omega Healthcare Correlation against competitors.

Latest Omega Healthcare's Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Omega Healthcare Investors over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Omega Healthcare's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omega Healthcare's overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

Omega Common Stock Total Equity Regression Statistics

Arithmetic Mean17,556,519
Geometric Mean15,995,170
Coefficient Of Variation36.69
Mean Deviation5,395,077
Median19,614,000
Standard Deviation6,441,952
Sample Variance41.5T
Range23.2M
R-Value0.80
Mean Square Error16.3T
R-Squared0.64
Significance0.0004
Slope1,148,385
Total Sum of Squares581T

Omega Common Stock Total Equity History

202414.5 M
202326.9 M
202223.4 M
202123.9 M
202023.1 M
201922.7 M
201820.2 M

About Omega Healthcare Financial Statements

Investors use fundamental indicators, such as Omega Healthcare's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Omega Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Common Stock Total Equity26.9 M14.5 M

Currently Active Assets on Macroaxis

When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:
Check out the analysis of Omega Healthcare Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.137
Dividend Share
2.68
Earnings Share
1.36
Revenue Per Share
4.03
Quarterly Revenue Growth
0.14
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.